Bacteraemia in Europe—antimicrobial susceptibility data from the MYSTIC surveillance programme
- 29 February 2004
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 23 (2), 155-163
- https://doi.org/10.1016/j.ijantimicag.2003.07.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility testJournal of Antimicrobial Chemotherapy, 2001
- Extended-spectrum β-lactamasesSeminars in Respiratory Infections, 2000
- Nosocomial Bloodstream Infections: Organisms, Risk Factors, and ImplicationsClinical Infectious Diseases, 2000
- MeropenemDrugs, 2000
- MeropenemDrugs, 2000
- Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin AmericaInternational Journal of Antimicrobial Agents, 2000
- Bacteremia caused by multi-resistant Gram-positive microorganismsClinical Microbiology & Infection, 1999
- Nosocomial Bacteremia in Critically Ill Patients: A Multicenter Study Evaluating Epidemiology and PrognosisClinical Infectious Diseases, 1997
- Changing patterns of susceptibilities of blood, urinary and respiratory pathogens in Hong KongJournal of Hospital Infection, 1995
- The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory CommitteeJAMA, 1995